Fingerprint Dive into the research topics of 'PI3K inhibitor LY294002, as opposed to wortmannin, enhances AKT phosphorylation in gemcitabine-resistant pancreatic cancer cells'. Together they form a unique fingerprint.
- Sort by
- Weight
- Alphabetically
PI3K inhibitor LY294002, as opposed to wortmannin, enhances AKT phosphorylation in gemcitabine-resistant pancreatic cancer cells
Yufeng Wang, Yasuhiro Kuramitsu, Byron Baron, Takao Kitagawa, Kazuhiro Tokuda, Junko Akada, Shin Ichiro Maehara, Yoshihiko Maehara, Kazuyuki Nakamura
Research output: Contribution to journal › Article › peer-review
17
Citations
(Scopus)